Grade the Gausman Deal

[brooksfrankjim]

I say incomplete until we see what our total international haul is

[MurphDogg]

Just now, eddie83 said:

Then why did they make the deal? What good is the Int money? 

I guess we will find out. It was only meaningful as a trade asset to the Braves, they couldn't spend it anyway because they were over the limit in the past. Hopefully the Orioles use it and get something out of it. Would love to be wrong. A cost-controlled mid-rotation starter should bring back more.

[TheOtherRipken]

I struggle to see this as anything other than a terrible return.  Seems like it would have made more sense to see if Gausman could bounce back next year and maximize his value. 

[MurphDogg]

1 minute ago, Enjoy Terror said:

The whole thing reminds me Arrieta. A hugely talented pitcher that the Orioles can’t squeeze anything out of.

They had to trade Arrieta, he was unplayable at the end. Gausman was still a solid mid-rotation pitcher for the Orioles.

[MrOrange82]

17 minutes ago, Frobby said:

Simple poll.    Let’s see how it grades out.   

It's really not simple. As others have implied, it's actually premature. IMO, whatever international players the O's wind up signing should be strongly factored into the perceived quality of this trade. Just can't assess at this point.

[Number5]

Too soon to rate.  VVW is the key factor.  Clearly, both NYY and MIA were loading up in slot money to sign him away from us.  If we sign VVW, this is a A, IMO.

[ShoelesJoe]

A+ if the $$$ gets us VVM. If we drop the ball there then it’s a D. Hell, as things stand signing VVM is a mandatory next step or else the whole trade was a wasted opportunity. 

[Thato'sfan]

I voted B. Could be an A if we get VVM and some extra int'l prospects. We got a back end starter type in Zimmerman, A super high ceiling young 3b in Encarnacion, backup catcher with a moderate ceiling, MLB ready reliever with mid 90's fastball.

[Hallas]

If we are looking at this as Gausman, O’Day for the 4 prospects plus VVM and money saved, then I guess it’s fine.  I’d probably say B.  If we don’t land VVM this is almost certainly a D.  If we land VVM but have more than 2.5 million remaining in our bonus pool for this year when it expires, then this is maybe a C+.

[eddie83]

1 minute ago, MurphDogg said:

I guess we will find out. It was only meaningful as a trade asset to the Braves, they couldn't spend it anyway because they were over the limit in the past. Hopefully the Orioles use it and get something out of it. Would love to be wrong. A cost-controlled mid-rotation starter should bring back more.

It makes no sense to acquire that money if it isn’t going to be used. 

[El_Duderino]

Gausman was our second best chip - we turned that into our 4th best return. 

[ChipTait]

Both the pitchers coming back were born in Maryland.  Should help attendance numbers!  

[MurphDogg]

Just now, eddie83 said:

It makes no sense to acquire that money if it isn’t going to be used. 

Indeed. I guess time will tell. I don't have a ton of faith in the Orioles using all of their international slot money, and I have even less faith in them using it particularly well since they have such a limited amount of international scouting infrastructure.

[eddie83]

Just now, MurphDogg said:

Indeed. I guess time will tell. I don't have a ton of faith in the Orioles using all of their international slot money, and I have even less faith in them using it particularly well since they have such a limited amount of international scouting infrastructure.

Is this money isn’t for a top Int player then the deal makes no sense at all. 

[ChuckS]

I graded this an F.  Not a single top ten prospect back for a mid-rotation innings eater with 2.5 years of team control left. The return was poor, probably a D.  But the fact that there was no rush to trade the guy (not an expiring contract) and they jumped at this deal anyway, makes it an F for me.  

I'm not tough to please either.  I gave positive grades to both the Machado and Britton deal and will give a similar grade for the Schoop return.